Skip to main content

Table 3 Comparison of non-MP patients with MP cases

From: Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis

 

non-MP (n = 42)

MP (n = 10)

P value

Age (year)

58.2 ± 14.8

66.1 ± 9.1

.1113a

58.5 (16–86)

67.5 (49–77)

Sex (male/female)

11/31

5/5

.2509b

BMI (kg/m2)

22.5 ± 3.8

23.0 ± 2.3

.7024a

22.5 (16.0–31.4)

22.8 (19.5–27.7)

DM (yes/no)

5/37

3/7

.1710b

HT (yes/no)

14/28

6/4

.1562b

LDL-c (yes/no)

19/23

7/3

.2913b

TG (yes/no)

8/34

4/6

.2125b

Liver disease (yes/no)

0/42

1/9

.1923b

Herbal medicine treatment

   

 Ambulatory visit (years)

6.8 ± 4.3

13.9 ± 3.0

.0001c

6.3 (1.5–17.9)

15.1 (6.5–16.3)

 GF administration period (years)

4.2 ± 3.7

11.1 ± 3.5

.0001c

3.1 (0.2–14.8)

12.1 (1.5–15.9)

 Cumulative dosage of GF (g)

1319.7 ± 1077.7

8239.1 ± 3817.4

< .0001c

997.5 (54.0–4542.0)

6539.0 (5379.0–15792.0)

  1. Data are expressed as mean ± S.D. and median (minimum - maximum)
  2. MP mesenteric phlebosclerosis, BMI body mass index, DM diabetes mellitus, HT hypertension, LDL-c elevated low-density lipoprotein cholesterol, TG elevated triglyceride, GF gardenia fruit
  3. aComparison between non-MP group and MP group by Student’s t test
  4. bComparison between non-MP group and MP group by Fisher’s exact test
  5. cComparison between non-MP group and MP group by Mann-Whitney U-test